1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. LILLY(ELI) & CO
Lilly(Eli) & Co XNYS: LLY

Lilly(Eli) & Co Live Stock Price Today, Share Analysis and Chart

Expensive Performer
about

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumia...

Read More
839.87 20.02 (2.44%)
34.64% Gain from 52W Low
5.1M
XNYS Volume

XNYS 03 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert
Durability score
Medium Financial Strength
50.0 / 100
Valuation Score
Expensive Valuation
28.3 / 100
Momentum Score
Technically Neutral
54.1 / 100
Expensive Performer These stocks are with medium quality and mid-range technical aspects. However, their financials make them little expensive so choose the right moment to buy them. View Similar Embed DVM
Analyst Price Target
888
1Yr Price target upside is 6%
26 analysts

14

S

6

W

2

O

1

T

SWOT Analysis

Eli Lilly Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..